A股異動丨唐德影視(300426.SZ)漲超14% 與企鵝影視簽署影視劇集定製合同
格隆匯2月8日丨唐德影視(300426.SZ)高開高走,現漲幅擴大至逾14%,報6.28元,總市值26億元。唐德影視公佈,2021年2月5日,公司就一部古代傳奇題材影視劇集與上海騰訊企鵝影視文化傳播有限公司(“企鵝影視”)在深圳市南山區簽署了《影視劇集定製合同》,合同約定企鵝影視作為劇集的投資方和出品方,委託公司進行劇集製作,公司同意根據企鵝影視制定的標準和要求完成劇集製作。劇集製作費用預算總額為3.6億元,合同期限為自合同生效之日起至合同約定的權利與義務全部履行完畢之日止。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.